Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Acute upper respiratory tract infections are the most commmon infections in children and are associated with complications such as acute otitis media, sinusitis and pneumonia. Echinacea is widely used for treatment of upper respiratoty tract infections. The aim of this study is to evaluate its efficacy as prophilaxis in children 1-5 years old.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hormozgan University of Medical Sciences

Criteria

Inclusion Criteria:

• Childrens 1-5 years old

Exclusion Criteria:

• Wheezing in previous 3 months requiring bronchodilatator

• History of hyperactive reactive airway

• using steroid or Echinacea

• chronic pulmonary of cardiac disease

• Acute respiratory disease within one week before study

• Allergic rhinitis

• Allergy to Echinacea

• avoiding to participate in the study